Blog

  • People living with HIV exhibit altered central pain processing

    28 November 2019
    35 Views

    Conditioned pain modulation in people living with HIV (PLWH) is ineffective in comparison to healthy controls, found Owens et al. in their study published this year.

    Three groups were compared: PLWH with chronic pain, PLWH without chronic pain and healthy controls. Pain modulation was assessed through mechanical temporal summation (TS), heat TS at three different temperatures: 46, 48, and 50°C, and CPM with pressure pain thresholds as test stimuli, and cold pressor as conditioning.

    The authors found that mechanical TS was significantly greater in PLWH with chronic pain as compared to the PLWH without chronic pain or controls. Similarly, PLWH with chronic pain also had significantly more wind-up than both other groups at temperatures of 46 and 48 °C in the heat TS paradigm, though not at 50°C. Interestingly, both groups of PLWH showed no significant CPM effect, while the controls did. Controls significantly differed in their CPM effect from PLWH.
    PLWH with chronic pain had significant correlation between average pain severity and mechanical TS.
    These changes in pain modulation may signal vulnerability for developing chronic pain in PLWH, however more mechanistic research in this field is warranted.

    Medoc’s AlgoMed was used in the CPM paradigm, and Medoc’s TSA-II was used for the heat TS paradigm.

    Citation: Owens, Michael A., Romy Parker, Rachael L. Rainey, Cesar E. Gonzalez, Dyan M. White, Anooshah E. Ata, Jennifer I. Okunbor, Sonya L. Heath, Jessica S. Merlin, and Burel R. Goodin. “Enhanced facilitation and diminished inhibition characterizes the pronociceptive endogenous pain modulatory balance of persons living with HIV and chronic pain.” Journal of neurovirology 25, no. 1 (2019): 57-71.

    Link to the abstract: https://www.ncbi.nlm.nih.gov/pubmed/30414048

    Continue Reading
  • Pain goes through the stomach for veterans with Gulf War Illness

    10 November 2019
    114 Views

    Gulf War Illness (GWI) is presented by a number of health symptoms, among them pain complaints and gastro-intestinal (GI) issues in returning veterans who have served in the Persian Gulf War.

    A study by Zhou et al. from 2018 utilizing Medoc’s TSA-II used QST and compared between veterans suffering from GWI with GI complaints (GWI+GI), veterans with GWI without GI complaints, and healthy veterans. The experimental pain tests comprised of: Heat Pain Threshold, Cold Pressor Threshold, Ischemic Pain Threshold and Ischemic Pain Tolerance. Veterans with GWI+GI had significantly lower heat pain thresholds and cold pressor thresholds as compared to healthy veterans and veterans with GWI but no GI symptoms. There was no significant difference between healthy veterans and veterans with GWI but no GI symptoms. For the ischemic pain threshold and tolerance test both GWI veterans groups reached their respective levels before the healthy veterans. Moreover, average daily abdominal pain in GWI+GI veterans was significantly correlated with the experimental pain measures. These findings of increased pain sensitivity and their connection to GI symptoms in GWI veterans may point to convergence of visceral and somatic pain pathways, authors hypothesize.

    Source: Zhou, Q., Verne, M. L., Zhang, B., & Verne, G. N. (2018). Evidence for somatic hypersensitivity in veterans with Gulf war illness and gastrointestinal symptoms. The Clinical journal of pain, 34(10), 944-949.

    Picture source: Wikimedia Commons, U.S. DOD

    For the full-text article: https://journals.lww.com/clinicalpain/Fulltext/2018/10000/Evidence_for_Somatic_Hypersensitivity_in_Veterans.8.aspx

    Continue Reading
  • Are headaches common due to lacking conditioned pain modulation (CPM)?

    29 July 2019
    450 Views

    This question motivated Levy et al. to investigate the endogenous inhibition efficiency of the trigeminal and extra-trigeminal areas of the face, neck, and arm in healthy volunteers. Two TSA devices were used to allow thermal test and conditioning stimulation within these areas. CPM was tested in three different zones; 1) forehead (V1) and cheek (V3), 2) cheek and neck (C4), and 3) neck and arm (C7). Additionally, spatial summation of pain (SSP) and temporal summation (TS) of pain were tested on all four areas.

    Interestingly, the forehead was found to be least sensitive to heat pain, requiring the highest temperature to reach a VAS 5-6 pain rating. The only configuration that yielded a significant CPM response, was the neck and arm set-up, which did not involve any of the trigeminal sites. Spatial summation of pain was elicited in all four sites, and post-hoc analysis showed less spatial summation of pain in the forehead as compared to the other regions. Temporal summation of pain did not differ significantly between sites.

    This study showed inefficient pain modulation in trigeminal, as compared to extra-trigeminal areas. These findings could point to a possible factor in the etiology of pain syndromes involving the trigeminal area.

    To study CPM with two thermodes, you no longer need two TSAs, Our new TSA2, comes with standard dual-thermode abilities, allowing for advanced thermal stimulation protocols, with one portable device!

    For the article abstract:

    https://www.ncbi.nlm.nih.gov/pubmed/28990805

    Continue Reading
  • Is polyneuropathy reversible?

    18 June 2019
    605 Views

    A new study by Ng Wing Tin et al. suggests it might be.

    (more…)

    Continue Reading
  • Medoc will exhibit at NeuPSIG 2019

    21 April 2019
    666 Views

    Medoc Ltd. will exhibit at The 7th International Congress on Neuropathic Pain (NeuPSIG 2019), the international forum that provides the latest research and developments in understanding the mechanisms, assessment, prevention and treatment of neuropathic pain.

    The conference will be held this year on May 8-11 in London, and will focus on Diabetic Neuropathic Pain and Chemotherapy-induced Peripheral Neuropathic Pain.

    Join our MINI Symposium:

    “The use of Quantitative Sensory Testing in pharma-sponsored analgesic clinical trials: insights from recent trials” by Roi Treister. May 10th 12:45 at the Buckingham Room

    Attend the QST Workshop with Medoc devices:

    Hands-On workshop with leaders in the pain study field. May 10th 15:30-18:30 at the Windsor Suite

     

    You’re welcome to visit us at our Booth #202

    For the NeuPSIG scientific program

     

    Continue Reading
  • Thermal quantitative sensory testing proves pre-clinically relevant in type 2 Diabetes

    14 March 2019
    789 Views

    Thermal Quantitative Sensory testing (QST) is routinely performed in various diabetes clinics around the world to monitor for small fiber abnormalities.

    (more…)

    Continue Reading
  • Could Quantitative Sensory Testing help protect cancer patients from neuropathy?

    7 February 2019
    566 Views
    Comments are off for this post

    QST testing may detect subclinical neuropathy and hence, treatment may be adjusted in time.

    (more…)

    Continue Reading
  • QST identifies the better surgical skin graft technique

    24 January 2019
    479 Views
    Comments are off for this post

    QST identifies the better surgical skin graft technique:

    In a recent article published in the International Journal of Surgery, authors reported the use of a wide array of QST (quantitative sensory testing) techniques to identify which of three surgical flap techniques is the least damaging to sensory nerve function of the donor site.

    In this trial, which used Medoc’s TSA II and AlgoMed QST systems, thirty-one patients were included, by approximation equally divided among three types of surgical techniques. (more…)

    Continue Reading
  • Something to be optimistic about for 2019!

    2 January 2019
    623 Views
    Comments are off for this post
    Computerized Pressure Algometer

    What do the AlgoMed device, conditioned pain modulation and optimism have in common?

    (more…)

    Continue Reading
  • New technology may change the diagnosis and management of diabetic neuropathy

    15 November 2018
    672 Views
    Comments are off for this post
    World Diabetes Day

    Diabetic neuropathy is one of the most common complications seen in patients suffering from diabetes worldwide, with rates of neuropathies seen in up to 50% of diabetic patients (Gordois et al., 2003a; Gordois et al., 2003b). Medoc has been developing different tools which, with the use of thermal and vibratory stimuli, are able to evaluate the type and level of impairment in different nerve fibers. (more…)

    Continue Reading